The Epidemiology of Colorectal Cancer in Erbil

Hawro Taha Hamza (Medical Oncology Department, Oncology Center, Rizgary Teaching Hospital)
Kakil Ibrahim Rasul (National Center for Cancer Care and Research (NCCCR), Weil Cornell Medical College)


Colorectal cancer (CRC) is a major cause of morbidity and cancer related mortality throughout the world. It is the third most common cancer worldwide and the fourth most common cause of cancer-related death. The objective of this study is to study the epidemiology of colorectal cancer patients in Erbil city. Retrospective analysis of the data that was collected from registry units in Rizgary Oncology Center and Nanakaly Cancer Hospital in Erbil city during the period of Jan 2016–Dec 2016. Data of total 118 patients collected, 55.08% of patients were male and 44.92% were female with a male to female ratio of approximately “1.22:1”. The highest number of patients was in the age range of 60–69 years. The presence of 77.12% of patients with left side tumors makes that side the most common. The presence of 41.53% of the patients in stage III makes that stage majority. The most common histopathological type was adenocarcinoma not otherwise specified (NOS) by 90.68% of the patients. Overall one-year survival was 77.1%. The one-year survival of rectal tumors is 66%. Conclusions: The study concluded that the male to female ratio is “1.22:1”. The highest number of patients was in the age range of 60–69 years. The percentage of patients below the age of 40 years was 20.51%. The increasing proportion of young age CRC cases recorded in Iraq may be due to the young age-structure of this country. Two thirds of the patients were in the advanced stages (stage III and IV). Overall one-year survival was 77.1%.


Colorectal cancer; Colon cancer; Rectal cancer; Epidemiology; Survival

Full Text:



[1]Haggar FA, Boushey RP. Colorectal cancer epidemiology: Incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 2009; 22(4): 191–197. doi: 10.1055/s-0029-1242458.

[2]Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: A global perspective. Proc Nutr Soc 2008; 67(3): 253–256. doi: 10.1017/S002966510800712X.

[3]World Health Organization, International Agency for Research on Cancer, GLOBOCAN 2012. Available from:

[4]Jemal A, Center MM, DeSantis C, Ward EM. Global patterns

[5]of cancer incidence and mortality rates and trends. Cancer

[6]Epidemiol Biomarkers Prev 2010; 19(8): 1893–1907. doi:


[8]Atkin WS, Northover JM, Cuzick J, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 1993;341(8847):736–740.

[9]Bülow S. Colorectal cancer in patients less than 40 years of age in Denmark, 1943–1967. Dis Colon Rectum 1980; 23(5):327–336.

[10]Griffin PM, Liff JM, Greenberg RS, Clark WS. Adenocarcinomas of the colon and rectum in persons under 40 years old. Gastroenterology 1991; 100(4): 1033–1040.

[11]MacGillivray DC, Swartz SE, Robinson AM, Cruess DF, Smith LE. Adenocarcinoma of the colon and rectum in patients less than 40 years of age. Surg Gynecol Obstet 1991;172(1): 1–7.

[12]Guillem JG, Puig-La Calle J, Cellini C, Murray M, Ng J, et al. Varying features of early age-of-onset “sporadic” and hereditary nonpolyposis colorectal cancer patients. Dis Colon Rectum 1999; 42(1): 36–42.

[13]Mitry E, Benhamiche AM, Jouve JL, Clinard F, Finn-Faivre C, et al. Colorectal adenocarcinoma in patients under 45 years of age: Comparison with older patients in a well-defined French population. Dis Colon Rectum 2001; 44(3): 380–387.

[14]Al-Jaberi TM, Ammari F, Gharieybeh K, Khammash M, Yaghan RJ, et al. Colorectal adenocarcinoma in a defined Jordanian population from 1990 to 1995. Dis Colon Rectum 1997; 40(9): 1089–1094.

[15]Soliman AS, Bondy ML, Levin B, Hamza MR, Ismail K, et al. Colorectal cancer in Egyptian patients under 40 years of age. Int J Cancer 1997; 71(1): 26–30. doi: 10.1002/(SICI)1097-0215(19970328)71:1<26::AID-IJC6>3.0.CO;2-5.

[16]Davis DM, Marcet JE, Frattini JC, Prather AD, Mateka JJ, et al. Is it time to lower the recommended screening age for colorectal cancer? J Am Coll Surg 2011; 213(3): 352–361. doi: 10.1016/j.jamcollsurg.2011.04.033.

[17]Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60(5):277–300. doi: 10.3322/caac.20073.

[18]Wilmink AB. Overview of the epidemiology of colorectal cancer. Dis Colon Rectum 1997; 40(4): 483 Ann Intern Med. 493.

[19]Ahsan H, Neugut AI, Garbowski GC, Jacobson JS, Forde KA, et al. Family history of colorectal adenomatous polyps and increased risk for colorectal cancer. Ann Intern Med 1998; 128(11): 900–905. doi: 10.7326/0003-4819-128-11-199806010-00006.

[20]Bonbllj L, Martines H, Conio M, Bruzzi P, Aste H. Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel. A case-control study. Int J Cancer 1988; 41(4): 513–517. doi: 10.1002/ijc.2910410407.

[21]Hemminki K, Eng C. Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans. J Med Genet 2004; 41(11): 801–807. doi: 10.1136/jmg.2004.022731.

[22]Hemminki K, Chen B. Familial risk for colorectal cancers are mainly due to heritable causes. Cancer Epidemiol Biomarkers Prev 2004; 13(7): 1253–1256.

[23]Quintero E, Carrillo M, Leoz ML, Cubiella J, Gargallo C, et al. Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study. PLoS Med 2016; 13(5): e1002008. doi: 10.1371/journal.pmed.1002008.

[24]Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 2008; 26(35): 5783–5788. doi: 10.1200/JCO.2008.17.5950.

[25]Lynch HT, De la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348(10): 919–932. doi: 10.1056/NEJMra012242.

[26]Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006; 101(2): 385–398. doi: 10.1111/j.1572-0241.2006.00375.x.

[27]Nagy R, Sweet K, Eng C. Highly penetrant hereditary cancer syndromes. Oncogene 2004; 23(38): 6445–6470. doi: 10.1038/sj.onc.1207714.

[28]Le Marchand L, Wilkens LR, Kolonel LN, Hankin JH, Lyu LC. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 1997; 57(21): 4787–4794.

[29]Lin OS. Acquired risk factors for colorectal cancer. Methods Mol Biol 2009; 472: 361–372. doi: 10.1007/978-1-60327-492-0_16.

[30]Lieberman DA, Prindiville S, Weiss DG, Willett W. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003; 290(22): 2959–2967. doi:10.1001/jama.290.22.2959.

[31]Moore LL, Bradlee ML, Singer MR, Splansky GL, Proctor MH, et al. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord 2004; 28(4): 559–567. doi: 10.1038/sj.ijo.0802606.

[32]Rasul KI, Awidi AS, Mubarak AA, Al-Homsi UM. Study of colorectal cancer in Qatar. Saudi Med J 2001; 22 (8): 705–707.

[33]Dajani YF, Zayid I, Malatjalian DA, Kamal MF. Colorectal cancer in Jordan and Nova Scotia a comparative epidemiologic and histopathologic study. Cancer 1980; 46(2): 420–426.

[34]Ansari R, Mahdavinia M, Sadjadi A, Nouraie M, Kamangar F, et al. Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett 2006; 240(1): 143–147. doi: 10.1016/j.canlet.2005.09.004.

[35]Tomas D, Belicza M, Baličević D, Brezovečki-Biđin D, Ciglar D, et al. Colorectal Cancer Trends by Age and Sex Distribution, Anatomic Subsite and Survival (1989–2002). Acta Clinica Croatica 2003; 42(2): 175–178.

[36]Gomez D, Dalal Z, Raw E, Roberts C, Lyndon PJ. Anatomical distribution of colorectal cancer over a 10 year period in a district general hospital: Is there a true “rightward shift”? Postgrad Med J 2004; 80(949): 667–669. doi: 10.1136/pgmj.2004.020198.

[37]National Collaborating Centre for Cancer (UK. Colorectal cancer: the diagnosis and management of colorectal cancer).

[38]Cancer Research UK. Available from:

[39]Gao RN, Neutel CI, Wai E. Gender differences in colorectal cancer incidence, mortality, hospitalizations and surgical procedures in Canada. J Public Health (Oxf) 2008; 30(2):194–201. doi: 10.1093/pubmed/fdn019.

[40]SEER Cancer Stat Facts: Colon and Rectum Cancer. National Cancer Institute. Bethesda, MD. Available from:

[41]Qatar National Cancer Registry QNCR - Annual Report – 2015.

[42]Liang JT, Huang KC, Cheng AL, Jeng YM, Wu MS, et al. Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. Br J Surg 2003; 90(2): 205–214. doi: 10.1002/bjs.4015.

[43]Brozek W, Kriwanek S, Bonner E, Peterlik M, Cross HS. Mutual associations between malignancy, age, gender, and subsite incidence of colorectal cancer. Anticancer Res 2009; 29(9): 3721–3726.

[44]Adloff M, Arnaud JP, Schloegel M, Thibaud D, Bergamaschi R. Colorectal cancer in patients under 40 years of age. Dis Colon Rectum 1986; 29(5): 322–325.

[45]Abou-Zeid AA, Khafagy W, Marzouk DM, Alaa A, Mostafa I, et al. Colorectal cancer in Egypt. Dis Colon Rectum 2002; 45(9): 1255–1260. doi: 10.1097/01. DCR.0000027122.04363.74.

[46]Al-Jaberi TM, Yaghan RJ, El-Heis HA. Colorectal cancer in young patients under 40 years of age. Comparison with old patients in a well defined Jordanian population. Saudi Med J 2003; 24(8): 871–874.

[47]Isbister WH. Colorectal cancer below age 40 in the Kingdom of Saudi Arabia. Aust N Z J Surg 1992; 62(6): 468–472.

[48]Chung YF, Eu KW, Machin D, Ho JM, Nyam DC, et al. Young age is not a poor prognostic marker in colorectal cancer. Br J Surg 1998; 85(9): 1255–1259. doi: 10.1046/j.1365-2168.1998.00805.x.

[49]Okuno M, Ikehara T, Nagayama M, Sakamoto K, Kato Y, et al. Colorectal carcinoma in young adults. Am J Surg 1987; 154(3): 264–268.

[50]Parramore JB, Wei JP, Yeh KA, Fink AS. Colorectal cancer in patients under forty: Presentation and outcome/Discussion. Am Surg 1998; 64(6): 563.

[51]Torsello A, Garufi C, Cosimelli M, Diodoro MG, Zeuli M, et al. P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: Distribution and prognostic relevance. Eur J Cancer 2008; 44(9): 1217–1222. doi: 10.1016/j.ejca.2008.03.002.

[52]Öhman U. Colorectal carcinoma in patients less than 40 years of age. Dis Colon Rectum 1982; 25(3): 209–214.

[53]O’Connell JB, Maggard MA, Livingston EH, Cifford KY. Colorectal cancer in the young. The American Journal of Surgery 2004; 187(3): 343–348.

[54]Pal M. Proportionate increase in incidence of colorectal cancer at an age below 40 years: An observation. J Cancer Res Ther 2006; 2(3): 97–99.

[55]Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RG, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin 2017; 67(3): 177–193. doi: 10.3322/caac.21395.

[56]Surveillance, Epidemiology, and End Results (SEER) Program ( SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2016 Sub (2000-2014), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2017, based on the November 2016 submission.

[57]Acs AC. Cancer facts and figures 2010. American Cancer Society, National Home Office, Atlanta. 2010: 1–44.

[58]Maringe C, Walters S, Rachet B, Butler J, Fields T, et al. Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000–2007. Acta Oncol 2013; 52(5): 919–932. doi: 10.3109/0284186X.2013.764008.



  • There are currently no refbacks.
Copyright © 2018 Hawro Taha Hamza, Kakil Ibrahim Rasul Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.